U.S. market Closed. Opens in 1 day 3 hours 50 minutes

CANF | Can-Fite BioPharma Ltd. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue743.00K810.00K853.00K763.00K2.03M3.82M844.75K169.50K164.72KN/A1.78MN/A469.00K745.21K
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit743.00K810.00K853.00K763.00K2.03M3.82M844.75K169.50K164.72KN/A1.78MN/A469.00K745.21K
Operating Expenses8.94M10.91M13.70M14.90M14.04M9.23M8.22M8.80M6.58M7.13M8.99M6.00M5.27M4.51M
Selling, General & Admin2.96M3.14M3.85M2.95M3.06M3.16M2.95M2.70M2.70M2.94M4.52M2.48M1.86M1.69M
Research & Development5.98M7.76M9.85M11.95M10.98M6.08M5.27M6.08M3.86M4.16M4.42M3.52M3.41M2.82M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/A-20.64MN/AN/AN/AN/A
Operating Income-8.20M-10.10M-12.84M-14.14M-12.01M-5.41M-7.38M-8.63M-6.42M-7.13M-8.99M-5.99M-4.78M-3.76M
Other Expenses / Income561.00K-77.00K227.00K-304.00K-618.00K-1.15M781.00K319.00K1.39M840.28K496.03K137.58K-2.64M152.48K
Before Tax Income-7.63M-10.17M-12.62M-14.44M-12.62M-6.57M-4.95M-6.99M-5.06M-6.29M-8.85M-5.86M-7.42M-3.61M
Income Tax ExpensesN/A63.00K-20.00K363.00K427.00K4.00K29.92K29.12K4.35K5.91K2.58K2.94K50.18K66.23K
Net Income-7.63M-10.17M-12.62M-14.44M-12.62M-6.57M-6.34M-8.26M-6.24M-6.10M-8.38M-5.59M-6.70M-3.68M
Interest Expenses14.00K63.00K22.00K363.00K427.00K1.20M1.10M27.30K564.34K14.89K16.08K7.23K60.96K7.33K
Basic Shares Outstanding4.26M815.80M458.88M341.51M85.91M38.90M32.53M27.69M22.95M17.55M13.71M10.05M31.18K28.96K
Diluted Shares Outstanding4.26M815.75M553.08M358.41M85.91M38.90M32.53M27.69M22.95M17.55M13.71M10.05M31.18K28.96K
EBITDA-8.18M-10.08M-12.83M-14.13M-11.99M-6.54M-6.36M-8.68M-5.05M-6.82M-8.52M-5.65M-7.83M-3.36M
EBITDA Margin-1,100.94%-1,244.69%-1,503.87%-1,851.51%-590.21%-171.07%-752.53%-5,119.17%-3,064.72%0.00%-477.20%0.00%-1,669.57%-450.65%
EBIT-7.62M-10.05M-12.61M-13.72M-11.77M-5.36M-5.21M-8.20M-5.67M-6.08M-8.36M-5.58M-6.59M-3.60M
EBIT Margin-1,025.57%-1,240.37%-1,478.66%-1,797.77%-579.28%-140.39%-616.68%-4,838.11%-3,444.88%0.00%-468.27%0.00%-1,404.82%-483.62%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙